ArticleClinical & experimental metastasis2007

P53/MDM2 overexpression in metastatic endometrial cancer: correlation with clinicopathological features and patient outcome.

Ryszard Jeczen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.